SYNAPTOGENIX INC (SNPX)

US87167T3005 - Common Stock

4.36  +0.03 (+0.69%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
8.31M16.14M12.62M11.16M15.51M
Research and Development
1.97M6.32M4.34M3.07M4.54M
Selling, General, and Administrative Expenses
6.34M9.81M8.28M8.09M10.97M
Operating Income
-8.31M-16.14M-12.62M-11.16M-15.51M
Interest Income/Expense
905.35K2.16M10.00K150.00K380.00K
Other Income/Expense
1.37M8.41MN/AN/AN/A
Non Recurring Items
N/AN/A0.00-1.70MN/A
Income Before Taxes
-6.04M-5.57M-12.61M-12.70M-15.13M
Income Tax
0.000.000.000.000.00
Net Income
-13.78M-5.69M-12.61M-15.13M-15.13M
EBITDA
-8.31M-16.13MN/AN/AN/A
 
Per Share Data
EPS Diluted Total Ops
-29.56-0.81-2.51-12.00-11.45
Non GAAP EPS
N/A-2.07N/AN/AN/A
 
Statistics

All data in USD

Charts